Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.5468
+0.0306 (5.93%)
At close: Nov 6, 2026, 4:00 PM EST
0.5501
+0.0033 (0.60%)
Pre-market: Nov 9, 2026, 8:24 AM EST

RANI Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.881.631.03--2.72
Revenue Growth
306.42%58.85%---488.10%
Gross Profit
4.881.631.03--2.72
Operating Income
-32.96-38.31-49.6-66.1-63.45-51.6
Net Income
-30.14-29.67-30.02-33.97-30.59-8.33
Earnings Per Share
-0.22-0.45-1.05-1.33-1.28-0.43
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
53.3949.7127.6448.5498.48117.45
Total Debt
3.554.3229.7130.130.21-
Net Cash (Debt)
49.8445.39-2.0718.4468.27117.45
Net Cash Growth
----72.99%-41.88%69.52%
Net Cash Per Share
0.360.69-0.070.722.876.01

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-20.29-18.71-35.5-51.24-46.52-32.25
Capital Expenditures
-0.05-0.09-0.27-1.23-1.62-0.51
Free Cash Flow
-20.34-18.8-35.76-52.47-48.13-32.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%--100.00%
Operating Margin
-675.80%-2345.99%-4824.90%---1899.12%
Pretax Margin
-685.34%-2507.65%-5504.28%---1952.41%
Profit Margin
-618.02%-1817.09%-2920.04%---306.63%
FCF Margin
-417.04%-1151.38%-3478.99%---1205.41%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.6380.6544.39--118.62